Table 3. The results of NIH-CPSI of all patients.
| Parameter | Group 1 | Group 2 | ||||
|---|---|---|---|---|---|---|
| Before treatment | After treatment | Before treatment | After treatment | |||
| median value (range) | median value (range) | median value (range) | median value (range) | |||
| NIH-CPSI | ||||||
| Total score | 24.0 (21.0–32.0) | 19.0 (9.0–24.0) | 24.0 (16.0–33.0) | 11.0 (4.0–18.0)** | ||
| Pain subscore | 12.0 (7.0–18.0) | 8.0 (3.0–13.0) | 11.0 (7.0–18.0) | 5.0 (0–8.0)** | ||
| Urinary subscore | 6.0 (2.0–8.0) | 5.0 (1.0–7.0) | 6.0 (1.0–9.0) | 3.0 (1.0–5.0)* | ||
| QoL subscore | 8.0 (6.0–9.0) | 6.0 (4.0–8.0) | 8.0 (5.0–9.0) | 3.0 (2.0–4.0)** | ||
Abbreviations: NIH-CPSI, National Institute of Health Chronic Prostatitis Symptom Index; QoL, quality of life.
Group 1: chronic bacterial prostatitis with prostatic calculi; Group 2: chronic bacterial prostatitis without prostatic calculi.
Data presented as median values (range).
*P>0.05, **P<0.01, vs. Group 1.